Surgical microwave ablation for multifocal non-resectable liver metastases: a single institution experience treating five or more liver lesions

医学 微波消融 烧蚀 外科 结直肠癌 阶段(地层学) 回顾性队列研究 癌症 队列 放射科
作者
Jillian K. Wothe,Kendall R. McEachron,Schelomo Marmor,Jacob S. Ankeny,Christopher J. LaRocca,Benjamin Spilseth,Robben Schat,Eric H. Jensen
出处
期刊:Journal of gastrointestinal oncology [AME Publishing Company]
标识
DOI:10.21037/jgo-21-203
摘要

Thermal ablation is an effective treatment for patients with metastatic colon and rectal cancer and allows surgeons to offer curative intent therapy to patients who are otherwise not candidates for resection. We aimed to report outcomes of a single institution experience using microwave ablation (MWA) with or without resection to treat five or more liver metastases.In this retrospective cohort study, the University of Minnesota Division of Surgical Oncology liver surgery database was queried to identify all patients who underwent thermal ablation of five or more colorectal liver metastases (CRLM) between 2012-2018. We reviewed patient, disease, and tumor characteristics and measured local, intrahepatic, and extrahepatic recurrence (EHR) rates. We also calculated median overall survival (OS) and disease-free survival (DFS).Ten patients identified had five or more (range, 5-18) tumors ablated with or without combined liver and bowel resection. Median age was 50, and most patients were male (70%) and Caucasian (90%). Four patients received ablation alone (5-12 lesions), while six had combined resection and ablation (5-18 lesions). Ablation was performed laparoscopically in six patients, and four had ablations without resection. All patients received pre- and post-operative chemotherapy. A median of 7 tumors were ablated per patient. Median follow-up was 2.3 years. Among 75 tumors ablated, ablation site recurrence (ASR) (within 1 cm of ablation site) was seen in three with a per-lesion recurrence rate of 4%. Intrahepatic recurrence (IHR) occurred in 6 (60%) patients and EHR in 1 (10%). Five patients underwent retreatment of IHR during follow-up. Median OS was 3 years and DFS was 7.1 months. At the time of last follow up, 6 patients were disease-free.Thermal ablation can provide acceptable DFS and OS, even with high volume metastatic colorectal cancers. Future efforts should be focused on defining selection criteria for those most likely to benefit from this aggressive approach.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
3秒前
科研通AI2S应助智挂东南枝采纳,获得30
3秒前
负责冰烟发布了新的文献求助10
4秒前
丘比特应助Alina1874采纳,获得10
7秒前
豆丁发布了新的文献求助50
8秒前
什么都好完成签到 ,获得积分10
8秒前
陈敏发布了新的文献求助10
9秒前
11秒前
严以律己完成签到 ,获得积分10
12秒前
LIU发布了新的文献求助10
13秒前
Banbor2021完成签到,获得积分0
22秒前
bkagyin应助XHY采纳,获得10
23秒前
潜山耕之完成签到,获得积分10
24秒前
焱焱不忘完成签到 ,获得积分10
25秒前
甜甜球完成签到,获得积分10
25秒前
25秒前
29秒前
eden发布了新的文献求助10
29秒前
30秒前
Hello应助LIU采纳,获得10
32秒前
ckmen5发布了新的文献求助10
34秒前
Zz完成签到,获得积分10
35秒前
愉快无施完成签到,获得积分10
36秒前
香蕉觅云应助科研通管家采纳,获得10
38秒前
CodeCraft应助科研通管家采纳,获得10
38秒前
ding应助科研通管家采纳,获得10
38秒前
KFCckf完成签到,获得积分10
38秒前
40秒前
JamesPei应助bxl采纳,获得10
46秒前
杨家欢完成签到 ,获得积分10
46秒前
回忆告白完成签到,获得积分10
48秒前
49秒前
49秒前
KFCckf发布了新的文献求助10
52秒前
zhrcadd发布了新的文献求助10
53秒前
天天快乐应助wuyu采纳,获得10
53秒前
orixero应助白玉汤顿首采纳,获得10
53秒前
彭于晏应助卡夫卡的熊采纳,获得30
53秒前
深情安青应助超帅pzc采纳,获得10
54秒前
高分求助中
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Python Programming for Linguistics and Digital Humanities: Applications for Text-Focused Fields 500
Love and Friendship in the Western Tradition: From Plato to Postmodernity 500
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2548921
求助须知:如何正确求助?哪些是违规求助? 2176710
关于积分的说明 5605969
捐赠科研通 1897471
什么是DOI,文献DOI怎么找? 947024
版权声明 565447
科研通“疑难数据库(出版商)”最低求助积分说明 503985